This product contains a co-lyophilised blend of BPC-157 (10mg) and TB-500 (TB4) (10mg) in a single vial. It is not a blend of reconstituted solutions; both peptides are lyophilised together as a combined powder.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from human gastric juice protein. TB-500 is a synthetic analogue of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide found in virtually all human and animal cells.
In preclinical research, BPC-157 and TB-500 have been investigated individually across complementary models. BPC-157 research has focused on cytoprotective mechanisms, nitric oxide system modulation, and growth factor receptor expression. TB-500 research has focused on actin regulation, cell migration, angiogenesis, and inflammatory modulation.
This blend is supplied for laboratories investigating both compounds within the same experimental protocol. Researchers requiring separate compounds for independent assays should purchase individual BPC-157 and TB-500 products.
For In-Vitro Research Use Only. Not for human consumption, veterinary use, or clinical application. No dosing guidance is provided or implied.



